← Leaderboards
Eugene A Podrez
Cleveland Clinic Lerner Col/Med-Cwru
$10,424,141
Attributed
$11,199,313
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,199,313 · 6
By mechanism
R01$7,646,120 · 3
P01$3,553,193 · 3
Top collaborators
- Tatiana V Byzova2 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMolecularThrombosisIn VitroProteinsCellsFamilyLigandsPathway InteractionsReceptorStructureRegulationLinkSignal TransductionCd36 GeneBlood PlateletsPlatelet ActivationMediatingPlayAdhesionsAtherosclerosisPhospholipidsEventIn Vivo Model
Grant awards (35)
Novel oxidative pathway targets microglia in Alzheimer's disease$767,342
R01 · FY2025 · AG
Novel oxidative pathway targets microglia in Alzheimer's disease$783,003
R01 · FY2024 · AG
Scientific Core 1 (SC1) In Vivo and Imaging Core$195,588
P01 · FY2019 · HL · contact PI
Mechanism of atheroprotective function of Akt3 kinase$396,250
R01 · FY2018 · HL · contact PI
Pathophysiological Activities of of Oxidized Phospholipids$356,625
R01 · FY2018 · HL · contact PI
Scientific Core 1 (SC1) In Vivo and Imaging Core$191,676
P01 · FY2018 · HL · contact PI
Mechanism of atheroprotective function of Akt3 kinase$396,250
R01 · FY2017 · HL · contact PI
Pathophysiological Activities of of Oxidized Phospholipids$356,625
R01 · FY2017 · HL · contact PI
Scientific Core 1 (SC1) In Vivo and Imaging Core$195,587
P01 · FY2017 · HL · contact PI
Mechanism of atheroprotective function of Akt3 kinase$396,250
R01 · FY2016 · HL · contact PI
Pathophysiological Activities of of Oxidized Phospholipids$356,625
R01 · FY2016 · HL · contact PI
Scientific Core 1 (SC1) In Vivo and Imaging Core$195,587
P01 · FY2016 · HL · contact PI
Mechanism of atheroprotective function of Akt3 kinase$396,250
R01 · FY2015 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$356,625
R01 · FY2015 · HL · contact PI
Scientific Core 1 (SC1) In Vivo and Imaging Core$195,588
P01 · FY2015 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$332,931
R01 · FY2013 · HL · contact PI
Regulation of Integrin alphaIIbbetaIII Function bu Scavenger Receptor-B1$298,503
P01 · FY2013 · HL · contact PI
In vivo Core$201,943
P01 · FY2013 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$349,718
R01 · FY2012 · HL · contact PI
Regulation of Integrin alphaIIbbetaIII Function bu Scavenger Receptor-B1$313,552
P01 · FY2012 · HL · contact PI
In vivo Core$212,127
P01 · FY2012 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$353,250
R01 · FY2011 · HL · contact PI
Regulation of Integrin alphaIIbbetaIII Function bu Scavenger Receptor-B1$313,552
P01 · FY2011 · HL · contact PI
In vivo Core$212,128
P01 · FY2011 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$353,250
R01 · FY2010 · HL · contact PI
Regulation of Integrin alphaIIbbetaIII Function bu Scavenger Receptor-B1$313,552
P01 · FY2010 · HL · contact PI
In vivo Core$212,128
P01 · FY2010 · HL · contact PI
Regulation of Integrin alphaIIbbetaIII Function bu Scavenger Receptor-B1$329,192
P01 · FY2009 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$290,143
R01 · FY2009 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$219,888
R01 · FY2009 · HL · contact PI
In vivo Core$172,490
P01 · FY2009 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$290,143
R01 · FY2008 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$290,143
R01 · FY2007 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$298,809
R01 · FY2006 · HL · contact PI
Pathophysiological Activities of Oxidized Phospholipids$306,000
R01 · FY2005 · HL